PremiumThe FlyMedifast management to meet virtually with Stephens Medifast Faces Revenue Challenges Amid New Product Launch Medifast Reports 2024 Financial Results Amid Market Challenges PremiumThe FlyMedifast upgraded to Neutral from Underperform at DA Davidson Medifast Faces Revenue Decline Amid Strategic Adjustments Medifast Faces Revenue Decline, Ends Credit Agreement PremiumThe FlyMedifast reports Q2 adjusted EPS 92c, two estimates 39c Medifast (MED) Q2 Earnings Cheat Sheet DA Davidson analysts hold an analyst/industry conference call